Warning: This security is no longer trading.
defunct
Stemline Therapeutics, Inc. (STML): Price and Financial Metrics
STML Price/Volume Stats
| Current price | $11.83 | 52-week high | $18.22 |
| Prev. close | $12.00 | 52-week low | $3.21 |
| Day low | $11.82 | Volume | 17,354,300 |
| Day high | $12.10 | Avg. volume | 1,524,566 |
| 50-day MA | $8.63 | Dividend yield | N/A |
| 200-day MA | $8.77 | Market Cap | 621.21M |
STML Stock Price Chart Interactive Chart >
Stemline Therapeutics, Inc. (STML) Company Bio
Stemline Therapeutics is a clinical stage biopharmaceutical company developing novel therapeutics that target cancer stem cells (CSCs) and tumor bulk. The company was founded in 2003 and is based in New York, New York.
STML Latest News Stream
| Event/Time | News Detail | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
STML Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | N/A |
| 3-year | N/A |
| 5-year | -0.76% |
| YTD | N/A |
| 2024 | N/A |
| 2023 | N/A |
| 2022 | N/A |
| 2021 | N/A |
| 2020 | 0.00% |